Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica

Hepatitis B is an epidemiologic problem worldwide, with high mortality associated with acute and chronic liver damage and cancer. Chile has a low prevalence rate (under 2% of the population) but there has been an increase from 1.03% in the year 2000 to 1.52% in 2001. The groups with higher prevalenc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	ZUNINO M.,ENNA
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Chilena de Infectología 2002
Materias:	Hepatitis B Epidemiology Vaccine Chile Latin America
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182002000300002
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0716-10182002000300002
record_format	dspace
spelling	oai:scielo:S0716-101820020003000022002-11-21Epidemiología de la hepatitis B en Chile y esquemas de vacunación en LatinoaméricaZUNINO M.,ENNA Hepatitis B Epidemiology Vaccine Chile Latin America Hepatitis B is an epidemiologic problem worldwide, with high mortality associated with acute and chronic liver damage and cancer. Chile has a low prevalence rate (under 2% of the population) but there has been an increase from 1.03% in the year 2000 to 1.52% in 2001. The groups with higher prevalence rates being men that have sex with men, persons living with HIV, health care workers and in previous surveys, children with multiple transfusions. In Latin America the impact of HB infection is significant, there is an uneven distribution, with endemic areas of high, intermediate and low prevalence, even in the same country (eq. Brazil). The development of HB vaccines is one of the most cost effective and safe strategies of immunization, inducing long lasting immunity (> 10 years). Its impact has been great in countries where neonatal vaccination has been implemented and the goals of WHO/PAHO and more recently GAVI are directed to the universal vaccination of this aye group. To achieve these goals, problems of access and cost must be solved. In Latin America the use of the vaccine is in accordance with the epidemiology of the HB infection. Some countries like Brazil, have vaccination programs while others like Peru recommend and support it, but application is voluntary. In others it is restricted to population groups at risk. In our country HB vaccination was initially recommended to health care workers and other groups of risk. Later these recommendations were broadened to include students of the health care area and we are now evaluating its application in other groupsinfo:eu-repo/semantics/openAccessSociedad Chilena de InfectologíaRevista chilena de infectología v.19 n.3 20022002-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182002000300002es10.4067/S0716-10182002000300002
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Hepatitis B Epidemiology Vaccine Chile Latin America
spellingShingle	Hepatitis B Epidemiology Vaccine Chile Latin America ZUNINO M.,ENNA Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
description	Hepatitis B is an epidemiologic problem worldwide, with high mortality associated with acute and chronic liver damage and cancer. Chile has a low prevalence rate (under 2% of the population) but there has been an increase from 1.03% in the year 2000 to 1.52% in 2001. The groups with higher prevalence rates being men that have sex with men, persons living with HIV, health care workers and in previous surveys, children with multiple transfusions. In Latin America the impact of HB infection is significant, there is an uneven distribution, with endemic areas of high, intermediate and low prevalence, even in the same country (eq. Brazil). The development of HB vaccines is one of the most cost effective and safe strategies of immunization, inducing long lasting immunity (> 10 years). Its impact has been great in countries where neonatal vaccination has been implemented and the goals of WHO/PAHO and more recently GAVI are directed to the universal vaccination of this aye group. To achieve these goals, problems of access and cost must be solved. In Latin America the use of the vaccine is in accordance with the epidemiology of the HB infection. Some countries like Brazil, have vaccination programs while others like Peru recommend and support it, but application is voluntary. In others it is restricted to population groups at risk. In our country HB vaccination was initially recommended to health care workers and other groups of risk. Later these recommendations were broadened to include students of the health care area and we are now evaluating its application in other groups
author	ZUNINO M.,ENNA
author_facet	ZUNINO M.,ENNA
author_sort	ZUNINO M.,ENNA
title	Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
title_short	Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
title_full	Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
title_fullStr	Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
title_full_unstemmed	Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
title_sort	epidemiología de la hepatitis b en chile y esquemas de vacunación en latinoamérica
publisher	Sociedad Chilena de Infectología
publishDate	2002
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182002000300002
work_keys_str_mv	AT zuninomenna epidemiologiadelahepatitisbenchileyesquemasdevacunacionenlatinoamerica
_version_	1718439967837913088

Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica

Ejemplares similares